-
admin
Posts
Cuprina (Nasdaq: CUPR) to Acquire EBITDA-Positive Seven-Clinic Singapore Healthcare Group
Acquiring 100% of East Coast Podiatry (five clinics) and Orchard Clinic (two clinics) for approximately S$4.0 million (approximately US$3.1 million) Target Group generated FY2025 unaudited...
Thermoplastic Polyimide Market to Reach USD 0.86 Billion by 2032, at a CAGR of 7.4% — MarketsandMarkets™
Delray Beach, FL, Oct. 02, 2026 (GLOBE NEWSWIRE) — The global Thermoplastic Polyimide (TPI) Market is projected to grow from USD 0.56 billion in 2026...
EV Battery Recycling Market to Grow from USD 0.54 Billion in 2024 to USD 23.72 Billion by 2035, at a CAGR of 40.9% — MarketsandMarkets™
Delray Beach, FL , Oct. 02, 2026 (GLOBE NEWSWIRE) — MarketsandMarkets™ projects he global EV battery recycling market, by value, is estimated to be USD...
ATA Creativity Global Announces Receipt of a Bid Deficiency Notice from Nasdaq
Beijing, China, Oct. 02, 2026 (GLOBE NEWSWIRE) — ATA Creativity Global (“AACG” or the “Company”), (NASDAQ: AACG) announced today that on September 29, 2026, the Company received...
Hall Chadwick Acquisition Corp. and REEcycle Holdings, Inc. Announce Filing of Registration Statement on Form S-4 and Release Updated Investor Presentation
NEW YORK, Oct. 02, 2026 (GLOBE NEWSWIRE) — Hall Chadwick Acquisition Corp. (NASDAQ: HCAC) (the “Company”) and REEcycle Holdings, Inc. (“REEcycle”) jointly announced the filing...
Phaos Technology Holdings (Cayman) Limited Announces One-For-Fifteen Reverse Stock Split
SINGAPORE, Oct. 02, 2026 (GLOBE NEWSWIRE) — Phaos Technology Holdings (Cayman) Limited, (NYSE American: POAS), (“Phaos” or “the Company”), an advanced microscopy solutions headquartered in...
iTonic Holdings Ltd Announces 16-for-1 Share Consolidation Effective October 6, 2026
BEIJING, China, Oct. 02, 2026 (GLOBE NEWSWIRE) — iTonic Holdings Ltd (Nasdaq: ITOC) (the “Company”), a healthcare company developing digital medical technologies, today announced that...
Journal of Child Neurology Publishes Review Highlighting Dopamine’s Role in Tourette Syndrome and Ecopipam’s Selective D1 Receptor Mechanism for Tourette Syndrome in Pediatric Patients
The published review examines dopamine’s role in tic generation and how approved and investigational drugs may affect dopamine to reduce tics as well as synthesizes...
Decent Holding Inc. Announces Pricing of $1.23 Million Follow-on Offering
YANTAI, China, Oct. 02, 2026 (GLOBE NEWSWIRE) — Decent Holding Inc. (NASDAQ: DXST) (the “Company”), a technology-driven provider of wastewater treatment and community-based senior health...
Teva Presents New Efficacy and Safety Data with Ecopipam, an Investigational Treatment for Pediatric Patients with Tourette Syndrome
Based on a post hoc analysis, a majority of participants (~70%) experienced clinically meaningful tic reduction within 8 weeks of starting ecopipam An interim 18-month...